Queue Raises $12.6M in Seed Funding Led by AlleyCorp

The funding round follows a $6 million pre-seed round led by Riot Ventures less than a year ago. This new round was led by AlleyCorp, with participation from House Capital, Ubiquity Ventures, Grep Ventures, and Banter Capital, bringing total funding to $18.6 million.

The company plans to use the funds to speed up product development, expand deployments with enterprise pharmacy customers, and grow its engineering team.

Queue is entering the market at a critical time. Pharmacies are dealing with heavy workloads and low job satisfaction, with industry reports highlighting growing operational strain.

Read More:PCS Retirement Appoints Janis Benson as General Counsel

The shortage of pharmacists is expected to worsen, with schools graduating 3,000 to 4,000 fewer pharmacists than needed over the next five to six years. At the same time, pharmacy technician vacancies are reported at 40% or higher, increasing the risk of errors due to staff shortages.

In addition, many pharmacies are losing money on prescriptions because of “negative reimbursements,” adding financial pressure. Studies from USC and UC Berkeley show that nearly one in three pharmacies has closed since 2010, creating “pharmacy deserts.” These challenges are putting significant pressure on the $670.6 billion U.S. retail pharmacy market, forcing the industry to make difficult decisions ahead.

Queue’s solution is a fully autonomous robotic pharmacy designed to make prescription fulfillment faster, more accessible, and more cost-effective while maintaining strict safety and verification standards. The system can be seen in action HERE.

The platform works by taking sealed wholesale pill bottles at one end and producing filled and verified prescription vials at the other. It currently supports 250 of the most commonly prescribed medications in the United States.

“What the Queue team has accomplished is rare in the development of hardware for healthcare,” said Abe Murray, General Partner at AlleyCorp. “We decided to lead this funding round because we believe Queue is building critical infrastructure that can both increase accessibility for patients to get the prescriptions they need and use robotics and automation to improve labor constraints that exist across pharmacies greatly greatly.”

“Pharmacy has an infrastructure problem. While the industry has been forced to work around labor shortages, store closures and broken unit economics, Nick and Josh have taken a fundamentally different approach: automating the physical fulfillment layer itself,” said Will Coffield, Partner at Riot Ventures. “Queue is exactly the kind of company Riot backs early. It has exceptional founders solving a massive, urgent problem with technology that can deliver outsized impact.”

“Pharmacy in America is structurally broken,” said Josh Liu, co-founder & CTO of Queue. “Queue is a complete reimagining of how medications get dispensed, verified and delivered. We built the machine the industry has needed for decades, and the demand we’re seeing proves it.”

About Queue

Founded in 2025 by Nick Desai and Joshua Liu, Queue is headquartered in Palo Alto, California. The company is building the world’s first fully autonomous robotic pharmacy. Its robotic system fills and verifies prescriptions directly from sealed wholesale pill bottles without needing an on-site pharmacist. This helps reduce costs, and improve access to pharmacy services across retail, healthcare and underserved communities.

Read More:Associated Bank Hires Andy Miner as Senior Director